GenVault Corporation Appoints David Wellis CEO

CARLSBAD, CA -- (MARKET WIRE) -- January 03, 2007 -- GenVault Corporation today announced that David Wellis Ph.D. was appointed as its Chief Executive Officer effective December 14, 2006. Dr. Wellis brings more than 20 years experience in the life sciences and over 10 years experience in product commercialization in genomics. Dr. Wellis has served GenVault as its Senior Vice President of Marketing and Sales since December 2004 and its Vice President of Business Development and Marketing since April 2002.

"David combines strong leadership and communication skills with the technical depth and market vision required growing and establishing GenVault as the leader in biosample management," said James C. Blair, Ph.D. of Domain Associates and GenVault's Chairman.

Prior to GenVault, Dr. Wellis served as the Vice President of Functional Genomics of Axon Instruments Inc., which achieved a successful IPO in 2000. Dr. Wellis holds a B.S. in biological sciences from U.C. Irvine, an M.S. and Ph.D. in cell biology from Emory University and received postdoctoral training at Tufts University Medical School and U.C. Berkeley. Additionally, he received business training at the Leavey School of Business, Santa Clara University and U.C. Berkeley.

About GenVault

GenVault is the leader in providing DNA sample accessibility for genomic discovery, medicine and identification. GenVault serves customers across medical centers, academic institutions, pharmaceutical companies, and law enforcement agencies. As a scalable and reliable alternative to traditional freezers and DNA purification systems, GenVault's dry-state platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From its GenPlate to its Dynamic Archive solution, GenVault is continuously developing and refining best practices for DNA sample management. For more information visit us at www.genvault.com.

EDITORIAL CONTACTS:

David Wellis, GenVault (760) 268-5256 Email Contact

Agency Contact: Doug Forsyth, Alchymia Communications® LLC (541) 482-8744 Email Contact

SOURCE: GenVault Corporation

>>> Discuss This Story